1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Cardiovascular Devices Market Trends
  5. > MediPoint: Electrophysiology - APAC Analysis and Market Forecasts

MediPoint: Electrophysiology - APAC Analysis and Market Forecasts

Summary

Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics.

Growth in emerging markets is expected to drive sales as developing countries look to implement new EP programs, and hospitals adopt ablation techniques. Lastly, published studies, clinical evidence, and patient awareness will all contribute positively to EP market growth and will provide further evidence of the effectiveness of cardiac catheter ablation.

Scope

- An overview of electrophysiology, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized APAC electrophysiology market revenue from 2005 to 2013, forecast for 7 years to 2020.
- Investigation of current and future market competition for electrophysiology
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the electrophysiology sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL)

Reasons to buy

- Understand the trends shaping and driving APAC electrophysiology market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in the APAC electrophysiology market through 2020.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What’s the next big thing in the APAC electrophysiology market landscape? Identify, understand and capitalize.

Table Of Contents

MediPoint: Electrophysiology - APAC Analysis and Market Forecasts
1 Table of Contents

2 Introduction 21
2.1 Catalyst 21
2.2 Related Reports 21
3 Industry Overview 22
3.1 Introduction 22
3.2 Anatomy and Physiology 22
3.2.1 Etiology 23
3.2.2 Risk Factors 24
3.2.3 Types of Arrhythmia 25
3.3 Clinical Presentation 28
3.3.1 Symptoms 28
3.4 Diagnosis 29
3.4.1 Blood and Urine Diagnostic Procedures 29
3.4.2 Electrocardiography-Based Diagnostic Procedures 29
3.4.3 Computerized Tomographic Angiography 30
3.4.4 Electrophysiological Testing 31
3.4.5 Electromechanical Wave Imaging 31
3.4.6 Echocardiography 32
3.4.7 Tilt-Taable Testing 32
3.4.8 Diagnostic and Electrophysiological Studies 32
3.4.9 New York Heart Association Scale 32
3.4.10 American College of Cardiology Scale 33
3.5 Epidemiology 34
3.5.1 Prevalence 34
3.6 Market Segmentation 37
3.6.1 Electrophysiology Diagnostic Catheter 37
3.6.2 Electrophysiology Ablation Catheter 37
3.6.3 Electrophysiology Lab Systems 52
3.7 Treatment Costs, Pricing, and Reimbursement 52
3.7.1 Direct Costs 55
3.7.2 Indirect Costs 58
3.7.3 Pricing of Electrophysiology Devices and Equipment 59
3.7.4 Reimbursement 60
3.8 Market Characterization 62
3.8.1 Growing Patient Population Suitable for Treatment 62
3.8.2 Increasing Prevalence of Arrhythmia with Age 63
3.8.3 Emergence of Remote Catheter Navigation and Ablation Technology 65
3.8.4 Focus on the Development of “Single Shot” Devices 67
3.8.5 Catheter Localization Aided by Novel Mapping and Visualization Techniques 68
3.8.6 Electrophysiology Market Trends in Inorganic Growth through Consolidation 69
3.8.7 Lack of Skilled and Experienced Electrophysiologists to Negatively Impact Procedure Volumes and Hinder Market Growth 70
3.8.8 Awareness and Education to Drive Earlier Intervention 71
3.9 Regulatory Issues and Recalls 72
4 Segment Analysis 73
4.1 Ablation Catheters Market Dynamics 73
4.1.1 Ablation Catheters Market Drivers 73
4.1.2 Ablation Catheters Market Barriers 91
4.2 Diagnostic Catheters Market Dynamics 102
4.2.1 Diagnostic Catheters Market Drivers 102
4.2.2 Diagnostic Catheters Market Barriers 103
4.3 Lab Systems Market Dynamics 106
4.3.1 Lab Systems Market Drivers 106
4.3.2 Lab Systems Market Barriers 108
5 Market Outlooks by Geography 110
5.1 Japan 110
5.1.1 Overview 110
5.1.2 Market Analysis 110
5.2 China 118
5.2.1 Overview 118
5.2.2 Market Analysis 119
5.3 India 127
5.3.1 Overview 127
5.3.2 Market Analysis 128
6 Strategic Competitive Assessment 137
6.1 Key Company Share 137
6.1.1 Overview 137
6.1.2 Japan 138
6.1.3 China 139
6.1.4 India 140
7 Current and Future Players 142
7.1 Biosense Webster 142
7.1.1 Overview 142
7.1.2 Portfolio Evaluation 142
7.1.3 Biosense Webster SWOT Analysis 143
7.2 Biotronik 147
7.2.1 Overview 147
7.2.2 Portfolio Evaluation 147
7.2.3 Biotronik SWOT Analysis 148
7.3 Boston Scientific 153
7.3.1 Overview 153
7.3.2 Boston Scientific Acquires Bard EP and Rhythmia Medical 153
7.3.3 Portfolio Evaluation 154
7.3.4 Boston Scientific SWOT Analysis 157
7.4 CardioFocus 163
7.4.1 Overview 163
7.4.2 Portfolio Evaluation 164
7.4.3 Company SWOT Analysis 165
7.5 CardioInsight 168
7.5.1 Overview 168
7.5.2 Portfolio Evaluation 168
7.5.3 CardioInsight SWOT Analysis 169
7.6 Hansen Medical 171
7.6.1 Overview 171
7.6.2 Portfolio Evaluation 171
7.6.3 Company SWOT Analysis 172
7.7 Imricor 175
7.7.1 Overview 175
7.7.2 Portfolio Evaluation 175
7.7.3 Company SWOT Analysis 175
7.8 Japan Lifeline 178
7.8.1 Overview 178
7.8.2 Portfolio Evaluation 179
7.8.3 Company SWOT Analysis 179
7.9 Magnetecs Corporation 182
7.9.1 Overview 182
7.9.2 Portfolio Evaluation 182
7.9.3 Company SWOT Analysis 183
7.10 Medtronic 185
7.10.1 Overview 185
7.10.2 Portfolio Evaluation 186
7.10.3 Company SWOT Analysis 190
7.11 MicroPort Scientific Company 194
7.11.1 Overview 194
7.11.2 Portfolio Evaluation 194
7.11.3 MicroPort Scientific SWOT Analysis 195
7.12 St. Jude Medical 198
7.12.1 Overview 198
7.12.2 Portfolio Evaluation 198
7.12.3 Company SWOT Analysis 201
7.13 Stereotaxis 204
7.13.1 Overview 204
7.13.2 Portfolio Evaluation 204
7.13.3 Commercial Positioning 205
7.13.4 Company SWOT Analysis 206
7.14 Stryker Sustainability Solutions 212
7.14.1 Overview 212
7.14.2 Portfolio Evaluation 213
7.14.3 Company SWOT Analysis 214
7.15 Topera Medical 216
7.15.1 Overview 216
7.15.2 Portfolio Evaluation 217
7.15.3 Company SWOT Analysis 218
8 Pipeline Product Assessment 221
8.1 Pipeline Assessment by Development Stage 221
8.2 Segment Analysis of Pipeline Products 222
8.2.1 Ablation Catheter Pipeline Products 222
8.2.2 Diagnostic Catheter Pipeline Products 229
8.3 Lab Systems 230
8.3.1 Integrated X-Ray and Robotic Catheter System (Hansen Medical, Philips Healthcare) 230
8.3.2 ClearTrace System (MRI Interventions) 230
8.3.3 Robotic Catheter Guidance Lab System (North Carolina State University) 231
8.3.4 Catheter Guidance Lab System (SCR) 232
9 Strategic Deals Analysis 233
9.1 Key Acquisitions 233
9.1.1 Boston Scientific Acquires C.R. Bard's Electrophysiology Business for $275m 233
9.1.2 St. Jude Medical Acquires Endosense for $161m 233
9.1.3 Boston Scientific Acquires Rhythmia Medical for $265m 234
9.2 Key Partnerships 234
9.2.1 Philips and Biosense Webster Technology Integration Agreement 234
9.2.2 Biosense Webster Technology Integration Agreement with GE Healthcare Systems and Siemens Healthcare 234
9.2.3 Abbott and St. Jude Medical Broaden Alliance in US Cardiovascular Device Market 235
10 Appendix 236
10.1 Bibliography 236
10.2 Abbreviations 247
10.3 Report Methodology 252
10.3.1 Overview 252
10.3.2 Coverage 252
10.3.3 Secondary Research 253
10.3.4 Forecasting Methodology 253
10.3.5 Primary Research - Key Opinion Leader Interviews 254
10.3.6 Expert Panel Validation 255
10.4 Physicians Included in this Study 256
10.5 About the Authors 259
10.5.1 Analysts 259
10.5.2 Global Head of Healthcare 260
10.6 About MediPoint 261
10.7 About GlobalData 261
10.8 Disclaimer 261

1.1 List of Tables

Table 1: New York Heart Association Scale 33
Table 2: American College of Cardiology Scale 33
Table 3: Prevalent Cases of Congestive Heart Failure, APAC, Ages ?45 Years, Men and Women (N), 2012-2019 36
Table 4: Atrial Fibrillation Treatment Goals 39
Table 5: Reasons for Lack of Consensus on Site for Ablation 44
Table 6: Techniques for Treatment of Persistent and Permanent Atrial Fibrillation 45
Table 7: Types of Atrial Fibrillation based of Triggers 47
Table 8: Characteristics of Catheter Ablation by Arrhythmia Type (%) 49
Table 9: Rates of Occurrence of Major Complications with Catheter Ablation (%), 2003-2006 50
Table 10: Catheter Ablation Success for the Treatment of Atrial Fibrillation (%), Global, 1995-2002 and 2003-2006 51
Table 11: Catheter Ablation Success by Arrhythmia Type (%), 2009 52
Table 12: Classes of Recommendations 53
Table 13: Level of Evidence 53
Table 14: Estimation of Total Incremental Health Care Costs in Patients with Atrial Fibrillation ($), US, 2008 59
Table 15: Average Selling Price of Electrophysiology Products by Type, APAC, 2013 60
Table 16: Percentage of Population Age 65 and Older, by Country, 2010-2015 63
Table 17: Overview of the Applications, Benefits, Limitations, and Future Directions of Remote Navigation Systems in Electrophysiology 66
Table 18: Key Acquisitions in the Electrophysiology Devices Market 70
Table 19: Advantages and Disadvantages of Various Energy Sources Used for Catheter Ablation 81
Table 20: Experimental Theories of How Atrial Fibrillation Perpetuates 89
Table 21: Antiarrhythmic Drug Classification by Mode of Action 92
Table 22: Major Complications Associated with Catheter Ablation 96
Table 23: Complications Associated with Catheter Ablation 96
Table 24: Recently Approved and Investigational Antiarrhythmic Drugs Under Development 97
Table 25: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), Japan, 2013 112
Table 26: Ablation Catheters Market, Japan, Historic Revenue ($m), 2005-2013 113
Table 27: Ablation Catheters Market, Japan, Forecast Revenue ($m), 2013-2020 113
Table 28: Diagnostic Catheters Market, Japan, Historic Revenue ($m), 2005-2013 114
Table 29: Diagnostic Catheters Market, Japan, Forecast Revenue ($m), 2013-2020 115
Table 30: Lab Systems Market, Japan, Historic Revenue ($m), 2005-2013 116
Table 31: Lab Systems Market, Japan, Forecast Revenue ($m), 2013-2020 117
Table 32: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), China, 2013 121
Table 33: Ablation Catheters Market, China, Historic Revenue ($m), 2005-2013 122
Table 34: Ablation Catheters Market, China, Forecast Revenue ($m), 2013-2020 122
Table 35: Diagnostic Catheters Market, China, Historic Revenue ($m), 2005-2013 123
Table 36: Diagnostic Catheters Market, China, Forecast Revenue ($m), 2013-2020 124
Table 37: Lab Systems Market, China, Historic Revenue ($m), 2005-2013 125
Table 38: Lab Systems Market, China, Forecast Revenue ($m), 2013-2020 126
Table 39: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), India, 2013 130
Table 40: Ablation Catheters Market, India, Historic Revenue ($m), 2005-2013 131
Table 41: Ablation Catheters Market, India, Forecast Revenue ($m), 2013-2020 131
Table 42: Diagnostic Catheters Market, India, Historic Revenue ($m), 2005-2013 132
Table 43: Diagnostic Catheters Market, India, Forecast Revenue ($m), 2013-2020 133
Table 44: Lab Systems Market, India, Historic Revenue ($m), 2005-2013 134
Table 45: Lab Systems Market, India, Forecast Revenue ($m), 2013-2020 135
Table 46: Company Share, Japan, Total Electrophysiology Market Revenue (%), 2012 139
Table 47: Company Share, China, Total Electrophysiology Market Revenue (%), 2012 140
Table 48: Company Share, India, Total Electrophysiology Market Revenue (%), 2012 141
Table 49: Company Profile - Biosense Webster 142
Table 50: Biosense Webster, Electrophysiology Devices Portfolio 143
Table 51: SWOT Analysis - Biosense Webster 143
Table 52: Company Profile - Biotronik 147
Table 53: Biotronik, Electrophysiology Devices Portfolio 148
Table 54: SWOT Analysis - Biotronik 148
Table 55: Company Profile - Boston Scientific 154
Table 56: Boston Scientific, Electrophysiology Devices Portfolio 156
Table 57: SWOT Analysis - Boston Scientific 157
Table 58: Company Profile - CardioFocus 164
Table 59: CardioFocus, Electrophysiology Devices Portfolio 165
Table 60: SWOT Analysis - CardioFocus 165
Table 61: Company Profile - CardioInsight 168
Table 62: CardioInsight, Electrophysiology Devices Portfolio 168
Table 63: SWOT Analysis - CardioInsight 169
Table 64: Company Profile - Hansen Medical 171
Table 65: Hansen Medical, Electrophysiology Devices Portfolio 172
Table 66: SWOT Analysis - Hansen Medical 172
Table 67: Company Profile - Imricor 175
Table 68: SWOT Analysis - Imricor 175
Table 69: Company Profile - Japan Lifeline 178
Table 70: Japan Lifeline, Electrophysiology Devices Portfolio 179
Table 71: SWOT Analysis - Japan Lifeline 179
Table 72: Company Profile - Magnetecs Corporation 182
Table 73: Magnetecs Corporation, Electrophysiology Devices Portfolio 183
Table 74: SWOT Analysis - Magnetecs Corporation 183
Table 75: Company Profile - Medtronic 186
Table 76: Medtronic, Electrophysiology Devices Portfolio, 2013 189
Table 77: SWOT Analysis - Medtronic 190
Table 78: Company Profile - MicroPort Scientific Company 194
Table 79: MicroPort Scientific, Electrophysiology Devices Portfolio 195
Table 80: SWOT Analysis - MicroPort Scientific 195
Table 81: Company Profile - St. Jude Medical 198
Table 82: St. Jude Medical, Electrophysiology Devices Portfolio 200
Table 83: SWOT Analysis - St. Jude Medical 201
Table 84: Company Profile - Stereotaxis 204
Table 85: Stereotaxis, Electrophysiology Devices Portfolio 206
Table 86: SWOT Analysis - Stereotaxis 207
Table 87: Company Profile - Stryker Sustainability Solutions 213
Table 88: Stryker Sustainability Solutions, Electrophysiology Devices Portfolio 213
Table 89: SWOT Analysis - Stryker Sustainability Solutions 214
Table 90: Company Profile - Topera Medical 217
Table 91: Topera Medical, Electrophysiology Devices Portfolio, 2013 217
Table 92: SWOT Analysis - Topera Medical 218
Table 93: Ablation Catheter Pipeline Products 221
Table 94: Diagnostic Catheter Pipeline Products 221
Table 95: Lab Systems Pipeline Products 221
Table 96: Catheter Ablation Device, Product Status 222
Table 97: Ablation Catheter Device - Transcutaneous Monitoring to Avoid Hypercapnea during Complex Catheter Ablations 223
Table 98: Apama Medical Ablation Catheter, Product Status 224
Table 99: Cooled Tip Catheter, Product Status 224
Table 100: MaPP-CS, Product Status 225
Table 101: ROF-AC, Product Status 225
Table 102: ROF-AS, Product Status 226
Table 103: Vision MR Ablation Catheter, Product Status 226
Table 104: Voyager Irrigated RFA Catheter, Product Status 227
Table 105: Navigation and Ablation Catheter, Product Status 227
Table 106: Hot Balloon Catheter, Product Status 228
Table 107: Lesion Assessment Device, Product Status 229
Table 108: Horizon MR Recording System, Product Status 229
Table 109: Integrated X-Ray and Robotic Catheter System, Product Status 230
Table 110: ClearTrace System, Product Status 231
Table 111: Robotic Catheter Guidance Lab System, Product Status 231
Table 112: Catheter Guidance Lab System, Product Status 232
Table 113: Key Acquisitions in the Electrophysiology Market 233

1.2 List of Figures
Figure 1: Types of Arrhythmia 25
Figure 2: Pulmonary Vein Ablation Procedure 41
Figure 3: Antiarrhythmic Drugs and/or Ablation for Rhythm Control in Atrial Fibrillation 54
Figure 4: Cost Comparison of Ablation versus Antiarrhythmic Drug Therapy, 2009 56
Figure 5: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), Japan, 2013 112
Figure 6: Ablation Catheters Market, Japan, Historic Revenue ($m), 2005-2013 113
Figure 7: Ablation Catheters Market, Japan, Forecast Revenue ($m), 2013-2020 114
Figure 8: Diagnostic Catheters Market, Japan, Historic Revenue ($m), 2005-2013 115
Figure 9: Diagnostic Catheters Market, Japan, Forecast Revenue ($m), 2013-2020 116
Figure 10: Lab Systems Market, Japan, Historic Revenue ($m), 2005-2013 117
Figure 11: Lab Systems Market, Japan, Forecast Revenue ($m), 2013-2020 118
Figure 12: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), China, 2013 121
Figure 13: Ablation Catheters Market, China, Historic Revenue ($m), 2005-2013 122
Figure 14: Ablation Catheters Market, China, Forecast Revenue ($m), 2013-2020 123
Figure 15: Diagnostic Catheters Market, China, Historic Revenue ($m), 2005-2013 124
Figure 16: Diagnostic Catheters Market, China, Forecast Revenue ($m), 2013-2020 125
Figure 17: Lab Systems Market, China, Historic Revenue ($m), 2005-2013 126
Figure 18: Lab Systems Market, China, Forecast Revenue ($m), 2013-2020 127
Figure 19: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), India, 2013 130
Figure 20: Ablation Catheters Market, India, Historic Revenue ($m), 2005-2013 131
Figure 21: Ablation Catheters Market, India, Forecast Revenue ($m), 2013-2020 132
Figure 22: Diagnostic Catheters Market, India, Historic Revenue ($m), 2005-2013 133
Figure 23: Diagnostic Catheters Market, India, Forecast Revenue ($m), 2013-2020 134
Figure 24: Lab Systems Market, India, Historic Revenue ($m), 2005-2013 135
Figure 25: Lab Systems Market, India, Forecast Revenue ($m), 2013-2020 136
Figure 26: Company Share, Japan, Total Electrophysiology Market Revenue (%), 2012 139
Figure 27: Company Share, China, Total Electrophysiology Market Revenue (%), 2012 140
Figure 28: Company Share, India, Total Electrophysiology Market Revenue (%), 2012 141

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
European Market Report for Dialysis Catheters 2017 - MedCore

European Market Report for Dialysis Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European market for dialysis catheters comprises the acute hemodialysis, chronic hemodialysis and peritoneal dialysis catheter segments. The chronic hemodialysis catheter market is segmented ...

European Market Report for Port Needles 2017 - MedCore

European Market Report for Port Needles 2017 - MedCore

  • $ 5995
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description Over the forecast period, the total port needle market is expected to experience growth. The increase in market value will be driven by growth in the size and age of the European population ...

Denmark Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

Denmark Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

  • $ 5995
  • Industry report
  • September 2016
  • by Global Data

Denmark Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others Summary ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.